Andrew is a life sciences leader with over 15 years of experience in drug development. Most recently, Andrew oversaw the commercial organization at PicnicHealth, an AI real-world data company serving the evidence needs of leading biopharma. Previously, he advised biotech and pharma on key preclinical and clinical development strategies to accelerate and maximize the impact of new therapeutics. Andrew is a trained chemist who completed his postdoctoral fellowship and Ph.D. at the Johns Hopkins University School of Medicine in Cellular and Molecular Medicine.
